Patents signal- China leads the world with patent filings in pharma in Q2

[beijingwalker]

Patents signal- China leads the world with patent filings in pharma in Q2

July 18, 2023

Patent trends have been on the rise in inflammation, diabetes, and Alzheimer's disease, in line with rising drug revenues in those areas.

Each week, Pharmaceutical Technology’s journalists analyse data on patent filings and grants that illustrate innovation trends in our sector. These patent signals show where the leading companies are focusing their research and development investment, and why. We uncover key innovation areas in the sector and the themes that drive them.

This new, thematic patents coverage is powered by our underlying Disruptor data which tracks all major deals, patents, company filings, hiring patterns and social media buzz across our sectors.

This week, we take a look at geographic and therapy trends when it comes to patent filings by entities in the pharmaceutical space over Q2 2023. In that time period, China was a clear leader in terms of the number of patent grants. This was then followed by the US, Japan and South Korea.

Geographic distribution of patent filings in the pharmaceutical space in Q2. Source: GlobalData.

Patents allow biotech and pharmaceutical companies to stand out in the competitive therapeutic research and development landscape. Most patents filed in Q2 were related to inflammation-related research, followed closely by diabetes and Alzheimer’s disease. This is in line with recent trends with drugs in those therapy areas, especially diabetes and obesity, emerging as major revenue streams for companies.

Patents signal- China leads with patent filings in pharma in Q2 - Pharmaceutical Technology

Patent trends have been on the rise in inflammation, diabetes, and Alzheimer's disease, in line with rising drug revenues those areas.

www.pharmaceutical-technology.com

 

[Menthol]

Of course, China will become the biggest, since the population is huge.

Per capita, probably is not as high as other countries.

China is not a country, it's a continent by itself.

But still, China achievement is a good sign of progress and improvement.

 

[sinait]

Of course, China will become the biggest, since the population is huge.

Per capita, probably is not as high as other countries.

China is not a country, it's a continent by itself.

But still, China achievement is a good sign of progress and improvement.

Not really, China achievement is not just because of its huge population.
Rather it is because of its talented population.

Just huge population is not enough.
Pharmacy of the world, Supa Powa India is an example.
India don't have much to show in the number of patents despite its large population and their focus and emphasis on pharmaceuticals.

India recognised as pharmacy of the world: FM Nirmala Sitharaman

She said, "The Centre, along with state governments, executed vaccination at a rapid pace that by the time Omicron variant of Covid attacked us, we were prepared to face it... India could stand up to face the challenge because of the preparedness of a democratically-elected government."

economictimes.indiatimes.com

Dec 24, 2022

India recognised as pharmacy of the world:​

FM Nirmala Sitharaman​

.

 

[hari sud]

Must be easy to get patent in China without proper evaluation. Real test is when somebody from China proves in an American court of validity of his discovery. Until then all Chinese patents are like research papers published.

 

[beijingwalker]

Must be easy to get patent in China without proper evaluation. Real test is when somebody from China proves in an American court of validity of his discovery. Until then all Chinese patents are like research papers published.

Do all Indians live under a rock like you do?

China tops U.S. in quantity and quality of scientific papers

China tops U.S. in quantity and quality of scientific papers Report finds rapidly expanding Chinese research footprint while Japan falters The economic and technological rivalry between China and the U.S. only continues to grow. RYOSUKE MATSUZOE, Nikkei staff writer August 10, 2022 01:45 JST...

pdf.defence.pk